AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 SEP 2 - (NewsRx.com & NewsRx.net) -- According to a report from France, "In patients with primary hyperparathyroidism, a definite diagnosis is the first step in the management strategy and relies on appropriately selected and carefully interpreted laboratory tests.
"Parathyroid hormone assays are being increasingly performed as part of the routine evaluation of osteoporosis. In this setting, laboratory tests are often consistent with primary hyperparathyroidism but should be interpreted with caution," said C. Cormier and colleagues at the Cochin Teaching Hospital's Rheumatology Department, Paris, France.
"Bone mineral density [BMD] measurements are useful for assessing the impact of primary hyperparathyroidism," they continued.
In 2003, recommended BMD cutoffs for selecting patients requiring parathyroidectomy were lowered, with a subsequent rise in the number of surgically-treated patients.
"Parathyroidectomy remains the ...
Source: HighBeam Research, Parathyroid hormone assays for evaluation of bone loss need cautious...